Antitumoral Activities of Curcumin and Recent Advances to ImProve Its Oral Bioavailability
/in Curcuma, International Publications /von 2021-10-14 / Biomedicines 2021 Oct;9(10)Curcuma as an adjuvant in colorectal cancer treatment
/in Curcuma, International Publications /von 2021-10-09 / Life Sci 2021 Dec;286:120043Oncolytic Viro-Immunotherapy: An Emerging Option in the Treatment of Gliomas
/in Glioblastoma, International Publications, Newcastle Disease Virus /von 2021-10-05 / Front Immunol 2021;12:721830Oncolytic Newcastle disease virus expressing the co-stimulator OX40L as immunopotentiator for colorectal cancer therapy
/in Colorectal Cancer, International Publications, Newcastle Disease Virus /von 2021-10-04 / Gene Ther 2023 Feb;30(1-2):64-74Recent Advances in Experimental Dendritic Cell Vaccines for Cancer
/in Dendritic Cells, International Publications /von 2021-09-23 / Front Oncol 2021;11:730824The Role of Curcumin in Cancer Treatment
/in Curcuma, International Publications /von 2021-08-26 / Biomedicines 2021 Aug;9(9)Targeting CD166 lung cancer stem cells: Molecular study using murine dendritic cell vaccine
/in Dendritic Cells, International Publications, NSCLC, SCLC /von 2021-08-23 / Toxicol Appl Pharmacol 2021 Oct;429:115699Autologous Dendritic Cells in Combination With Chemotherapy Restore Responsiveness of T Cells in Breast Cancer Patients: A Single-Arm Phase I/II Trial
/in Breast Cancer, Dendritic Cells, International Publications /von 2021-08-20 / Front Immunol 2021;12:669965Curcumin as an Adjuvant to Cancer Immunotherapy
/in Curcuma, International Publications /von 2021-08-16 / Front Oncol 2021;11:675923
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de